{"preliminary_commentary":{"by_channel":{"x_thread":2,"podcast":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"SENOMAC-ULTRA","nct_id":"NCT06869629","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=senomac-ultra-nct06869629. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"SENOMAC-ULTRA","arms":[{"description":"Axillary lymph node dissection","label":"Axillary lymph node dissection","type":"ACTIVE_COMPARATOR"},{"description":"Removal of the marked metastasis/-es and a sentinel lymph node biopsy","label":"Targeted axillary dissection","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2041-12-31","type":"ESTIMATED"},"conditions":["Breast Carcinoma","Breast Cancer","Breast Surgery"],"enrollment":{"count":1380,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Targeted axillary dissection","otherNames":[],"type":"PROCEDURE"},{"name":"Axillary lymph node dissection","otherNames":[],"type":"PROCEDURE"}],"last_update":"2026-08-17","lead_sponsor":"Karolinska Institutet","official_title":"SENOMAC-ULTRA: A Prospective Randomised Trial on the Omission of Axillary Lymph Node Dissection in Ultrasound-detectable Axillary Metastases in Primary Breast Cancer Treated by Upfront Surgery","overall_status":"RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2031-12-31","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Recurrence-free survival","timeFrame":"5 years"}],"references":[{"citation":"de Boniface J, Meretoja T, Ryden L, Sund M, Karlsson P, Huang CS, Kim HJ, Ryu JM, Nash S, Offersen B, Dahl Nissen H, Wieslander E, Maggi N, Swedin L, Kuo SH, Tramm T, Dembrower K, Terata K, Nishibuchi I, Luna Tomas MA, Ciervide R, Lowery A, Skjerven HK, Ejlertsen B, Valachis A, Szulkin R, Spanic T, Shien T, Filtenborg Tvedskov T, Alkner S. Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial. BJS Open. 2026 Jul 3;10(4):zrag083. doi: 10.1093/bjsopen/zrag083.","pmid":"42551036","type":"DERIVED"}],"start_date":{"date":"2026-05-13","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer","url":"https://clinicaltrials.gov/study/NCT06869629"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/senomac-ultra-nct06869629"}